PEN - Penumbra Inc Stock Price, Fair Value and News

210.19USD-7.26 (-3.34%)Market Closed

Market Summary

USD210.19-7.26

Market Closed

-3.34%

PEN Alerts

1 major insider sales recently.

PEN Stock Price

View Fullscreen

PEN RSI Chart

PEN Valuation

Market Cap

8.1B

Price/Earnings (Trailing)

89.44

Price/Sales (Trailing)

7.69

EV/EBITDA

74.53

Price/Free Cashflow

99.06

PEN Price/Sales (Trailing)

PEN Profitability

Operating Margin

64.49%

EBT Margin

7.52%

Return on Equity

7.71%

Return on Assets

5.84%

Free Cashflow Yield

1.01%

PEN Fundamentals

PEN Revenue

Revenue (TTM)

1.1B

Rev. Growth (Yr)

28.69%

Rev. Growth (Qtr)

5.07%

PEN Earnings

Earnings (TTM)

91.0M

Earnings Growth (Yr)

1.3K%

Earnings Growth (Qtr)

488.43%

Breaking Down PEN Revenue

Last 7 days

-4.5%

Last 30 days

-5.4%

Last 90 days

-20.1%

Trailing 12 Months

-24.3%

How does PEN drawdown profile look like?

PEN Financial Health

Current Ratio

6.06

PEN Investor Care

Shares Dilution (1Y)

1.37%

Diluted EPS (TTM)

2.31

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	884.6M	937.8M	995.1M	1.1B
2022	782.3M	806.4M	829.9M	847.1M
2021	592.3M	671.4M	710.5M	747.6M
2020	556.3M	527.2M	538.8M	560.4M
2019	470.7M	495.2M	522.9M	547.4M
2018	363.3M	392.3M	420.2M	444.9M
2017	278.6M	294.1M	310.8M	333.8M
2016	205.1M	227.9M	244.6M	263.3M
2015	138.3M	149.1M	167.1M	186.1M
2014	98.0M	107.2M	116.3M	125.5M
2013	0	0	0	88.8M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Penumbra Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 01, 2024	roberts johanna	sold	-130,242	217	-600	evp, gen. counsel & secretary
Apr 01, 2024	kassing don w.	sold	-37,940	223	-170	-
Mar 15, 2024	roberts johanna	acquired	-	-	2,070	evp, gen. counsel & secretary
Mar 15, 2024	shiu lambert	sold (taxes)	-51,538	222	-232	chief accounting officer
Mar 15, 2024	roberts johanna	sold (taxes)	-41,319	222	-186	evp, gen. counsel & secretary
Mar 15, 2024	shiu lambert	acquired	-	-	1,670	chief accounting officer
Mar 15, 2024	yuen maggie	sold (taxes)	-42,874	222	-193	chief financial officer
Mar 15, 2024	yuen maggie	acquired	-	-	2,070	chief financial officer
Mar 06, 2024	elsesser adam	acquired	38,750	7.75	5,000	ceo and president
Mar 04, 2024	bose arani	sold	-1,876,500	250	-7,500	-

Which funds bought or sold PEN recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 12, 2024	AdvisorNet Financial, Inc	sold off	-100	-252	-	-%
Apr 11, 2024	Roble, Belko & Company, Inc	unchanged	-	-	1,000	-%
Apr 11, 2024	17 CAPITAL PARTNERS, LLC	unchanged	-	-36,329	285,894	0.21%
Apr 11, 2024	CONGRESS ASSET MANAGEMENT CO /MA	added	375	4,523,870	5,931,230	0.04%
Apr 10, 2024	CVA Family Office, LLC	unchanged	-	-425	3,348	-%
Apr 10, 2024	Banque Cantonale Vaudoise	sold off	-100	-161,000	-	-%
Apr 09, 2024	MASSMUTUAL TRUST CO FSB/ADV	added	4.21	-1,801	22,095	-%
Apr 09, 2024	MATHER GROUP, LLC.	new	-	33,203	33,203	-%
Apr 05, 2024	CWM, LLC	reduced	-3.91	-19,000	110,000	-%
Apr 05, 2024	GAMMA Investing LLC	added	9.88	-564	19,863	-%

Are Funds Buying or Selling PEN?

Are funds buying PEN calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own PEN

No. of Funds

PEN Alerts

1 major insider sales recently.

Unveiling Penumbra Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	price t rowe associates inc /md/	8.0%	3,105,828	SC 13G
Feb 13, 2024	vanguard group inc	9.48%	3,658,102	SC 13G/A
Feb 09, 2024	capital research global investors	6.9%	2,677,789	SC 13G/A
Feb 09, 2024	fmr llc	-	0	SC 13G/A
Jan 24, 2024	blackrock inc.	10.4%	4,000,277	SC 13G/A
Feb 13, 2023	capital research global investors	6.1%	2,321,719	SC 13G/A
Feb 09, 2023	fmr llc	-	0	SC 13G/A
Feb 09, 2023	vanguard group inc	9.13%	3,467,792	SC 13G/A
Jan 23, 2023	blackrock inc.	11.6%	4,422,738	SC 13G/A
Oct 07, 2022	blackrock inc.	10.3%	3,904,542	SC 13G/A

Recent SEC filings of Penumbra Inc

View All Filings

Date Filed	Form Type	Document
Apr 03, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading
Apr 01, 2024	144	Notice of Insider Sale Intent
Mar 21, 2024	8-K	Current Report
Mar 19, 2024	4	Insider Trading
Mar 19, 2024	4	Insider Trading
Mar 19, 2024	4	Insider Trading
Mar 08, 2024	4	Insider Trading
Mar 05, 2024	4	Insider Trading
Mar 05, 2024	4	Insider Trading

Peers (Alternatives to Penumbra Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	188.9B	40.1B	-5.73%	4.72%	33.01	4.71	-8.12%	-17.45%
BDX	67.8B	19.5B	-0.88%	-8.17%	53.97	3.48	4.02%	-22.04%
ALGN	22.9B	3.9B	-3.10%	-11.00%	51.41	5.92	3.42%	23.09%
BAX	20.3B	14.8B	-3.77%	-6.99%	7.66	1.37	2.12%	209.17%
MID-CAP
ATR	9.1B	3.5B	-1.99%	15.94%	32.07	2.62	4.97%	18.89%
HSIC	9.1B	12.3B	-5.16%	-14.19%	21.85	0.74	-2.44%	-22.68%
BIO	8.8B	2.7B	-9.88%	-37.29%	-13.77	3.29	-4.68%	82.43%
XRAY	6.4B	4.0B	-5.94%	-24.93%	-47.62	1.62	1.10%	85.84%
AXNX	3.4B	366.4M	-0.71%	17.46%	-565.84	9.37	33.86%	89.83%
PDCO	2.3B	6.6B	-6.94%	-4.63%	11.73	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	-3.79%	-17.24%	-1.94	0.41	7.73%	-1066.14%
ANIK	376.4M	166.7M	-0.35%	-8.55%	-4.55	2.26	6.67%	-456.34%
ANGO	253.5M	324.0M	17.88%	-30.36%	-1.32	0.78	-3.19%	-337.41%
APYX	47.8M	52.3M	-22.91%	-54.00%	-2.55	0.91	17.61%	19.28%
AEMD	3.8M	3.7M	-16.18%	262.50%	-0.31	1.01	5.77%	8.23%

Penumbra Inc News

Latest updates

Penumbra Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	5.1%	284,679	270,946	261,499	241,398	221,216	213,678	208,344	203,895	204,011	190,117	184,258	169,204	166,898	151,076	105,109	137,329	145,263	139,502	134,201	128,439	120,793
Cost Of Revenue	4.8%	97,687	93,228	94,638	90,326	82,789	78,351	74,309	76,477	78,564	70,205	65,572	57,867	72,585	60,153	40,179	49,320	47,135	43,504	40,273	44,529	42,081
Gross Profit	5.2%	186,992	177,718	166,861	151,072	138,427	135,327	134,035	127,418	125,447	119,912	118,686	111,337	94,313	90,923	64,930	88,009	98,128	95,998	93,928	83,910	78,712
Operating Expenses	-8.0%	151,963	165,093	148,972	143,064	133,594	129,893	134,174	131,464	165,504	111,131	108,374	97,874	96,058	111,081	82,579	87,399	87,549	83,022	81,127	72,758	72,043
S&GA Expenses	3.3%	130,021	125,920	127,435	123,078	115,630	108,573	114,615	110,900	113,500	94,397	90,636	79,798	76,603	76,158	59,854	74,453	74,688	69,289	67,665	61,091	61,176
R&D Expenses	-	-	-	21,537	19,986	-	21,320	19,559	20,564	-	16,734	17,738	18,076	-	34,923	22,725	12,946	-	13,733	13,462	11,667	10,867
EBITDA Margin	33.5%	0.10*	0.08*	0.07*	0.05*	0.03*	-0.02*	-0.02*	-0.01*	0.01*	0.06*	0.02*	-0.02*	-	-	-	-	-	-	-	-	-
Income Taxes	-492.7%	-16,060	4,090	576	90.00	3,251	5,306	2,520	-5,183	-16,321	-249	1,904	1,541	-3,143	-9,855	-4,129	-1,634	2,448	1,963	-2,735	1,455	885
Earnings Before Taxes	186.8%	38,158	13,304	19,536	8,652	7,128	3,035	-1,167	-5,104	-40,954	7,782	10,203	12,467	-511	-19,731	-17,030	-746	11,749	12,963	13,514	11,909	7,349
EBT Margin	54.0%	0.08*	0.05*	0.04*	0.02*	0.00*	-0.05*	-0.05*	-0.04*	-0.01*	0.04*	0.00*	-0.04*	-	-	-	-	-	-	-	-	-
Net Income	488.4%	54,218	9,214	18,960	8,562	3,877	-2,271	-3,687	79.00	-24,633	8,850	9,231	11,836	3,648	-8,815	-11,960	1,425	9,689	11,483	16,588	10,698	6,659
Net Income Margin	110.5%	0.09*	0.04*	0.03*	0.01*	0.00*	-0.04*	-0.02*	-0.01*	0.01*	0.05*	0.02*	-0.01*	-	-	-	-	-	-	-	-	-
Free Cashflow	18.6%	32,616	27,512	12,757	9,235	-2,225	-19,257	-44,006	-9,471	-17,362	30,648	-6,605	-18,359	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4	2018Q3
Assets	6.0%	1,556	1,468	1,433	1,395	1,371	1,322	1,328	1,302	1,244	973	841	823	810	780	664	666	614	585	569	558	501
Current Assets	5.4%	915	868	828	786	756	724	718	690	681	668	635	618	590	576	454	463	451	435	423	410	398
Cash Equivalents	66.2%	167	101	114	95.00	70.00	55.00	58.00	68.00	59.00	66.00	56.00	70.00	80.00	134	72.00	73.00	112	77.00	96.00	68.00	48.00
Inventory	3.7%	388	374	359	344	334	320	296	274	264	258	245	220	192	183	166	153	140	133	122	116	110
Net PPE	10.8%	73.00	66.00	66.00	65.00	65.00	64.00	63.00	60.00	59.00	57.00	50.00	48.00	65.00	62.00	59.00	52.00	46.00	38.00	35.00	35.00	34.00
Goodwill	0.2%	166	166	166	166	166	165	166	166	166	159	8.00	8.00	8.00	8.00	8.00	8.00	7.00	8.00	8.00	8.00	8.00
Liabilities	3.6%	377	364	366	371	372	348	358	342	290	289	190	185	191	157	176	180	147	131	132	93.00	92.00
Current Liabilities	4.2%	151	145	144	146	145	138	146	130	123	116	112	106	108	78.00	88.00	91.00	86.00	70.00	69.00	66.00	65.00
Shareholder's Equity	6.8%	1,179	1,104	1,067	1,024	999	974	970	959	954	685	650	638	620	623	488	486	467	454	437	422	409
Retained Earnings	67.2%	135	81.00	71.00	52.00	44.00	40.00	42.00	46.00	46.00	71.00	52.00	41.00	37.00	46.00	58.00	58.00	48.00	36.00	20.00	9.00	2.00
Additional Paid-In Capital	1.6%	1,047	1,031	1,001	979	963	947	938	919	911	621	603	598	585	581	436	431	423	419	420	415	408
Shares Outstanding	0.9%	39.00	38.00	38.00	38.00	38.00	38.00	38.00	38.00	38.00	37.00	36.00	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-6.20	-4.62	-3.71	-2.69	-1.63	-0.82	-0.28	-0.39	0.00	-0.07	0.00	-0.13
Float	-	-	-	12,700	-	-	-	4,500	-	-	-	-	-	-	6,000	-	-	-	5,100	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	17.6%	36,261	30,844	17,099	13,129	1,337	-12,909	-39,575	-4,514	-9,270	36,450	-3,310	-14,368	-2,083	-3,550	-21,689	-5,920	4,767	22,050	1,903	-2,068	7,531
Share Based Compensation	-23.7%	10,791	14,136	12,823	12,766	9,997	9,702	8,786	8,893	41,662	7,903	9,803	6,395	8,055	6,238	5,559	5,689	5,014	6,241	5,135	5,095	4,871
Cashflow From Investing	154.7%	24,280	-44,396	-6,671	10,711	8,633	9,786	20,660	15,711	-1,339	-49,831	26,345	3,090	-10,226	-49,416	-54,544	10,037	-43,734	14,281	-15,113	31,855	9,625
Cashflow From Financing	2692.9%	5,921	212	8,694	1,376	5,735	-603	9,131	-2,641	2,961	-2,684	3,173	-2,614	2,457	-1,651	138,461	-4,350	-502	-1,439	-5,308	-1,710	3,168

PEN Income Statement

2023-12-31

Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Revenue	$ 1,058,522	$ 847,133	$ 747,590
Cost of revenue	375,879	311,926	272,208
Gross profit	682,643	535,207	475,382
Operating expenses:
Research and development	84,423	79,407	104,552
Sales, general and administrative	506,454	449,718	378,331
Acquired in-process research and development	18,215	0	0
Total operating expenses	609,092	529,125	482,883
Income (loss) from operations	73,551	6,082	(7,501)
Interest and other income (expense), net	6,099	(2,190)	(3,001)
Income (loss) before income taxes	79,650	3,892	(10,502)
(Benefit from) provision for income taxes	(11,304)	5,894	(13,125)
Consolidated net income (loss)	90,954	(2,002)	2,623
Net loss attributable to non-controlling interest	0	0	(2,661)
Net income (loss) attributable to Penumbra, Inc.	$ 90,954	$ (2,002)	$ 5,284
Net income (loss) attributable to Penumbra, Inc. per share:
Net income (loss) attributable to Penumbra, Inc. per share: Basic (in dollars per share)	$ 2.37	$ (0.05)	$ 0.14
Net income (loss) attributable to Penumbra, Inc. per share: Diluted (in dollars per share)	$ 2.32	$ (0.05)	$ 0.14
Weighted average shares outstanding:
Weighted average shares outstanding: Basic (in shares)	38,401,171	37,841,874	36,764,290
Weighted average shares outstanding: Diluted (in shares)	39,216,564	37,841,874	37,881,180

PEN Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 167,486	$ 69,858
Marketable investments	121,701	118,172
Accounts receivable, net of allowance for credit losses of $3,169 and $862 at December 31, 2023 and 2022, respectively	201,768	203,384
Inventories	388,023	334,006
Prepaid expenses and other current assets	36,424	30,279
Total current assets	915,402	755,699
Property and equipment, net	72,691	65,015
Operating lease right-of-use assets	188,756	192,636
Finance lease right-of-use assets	31,092	33,323
Intangible assets, net	71,056	81,161
Goodwill	166,270	166,046
Deferred taxes	85,158	64,213
Other non-current assets	25,880	12,793
Total assets	1,556,305	1,370,886
Current liabilities:
Accounts payable	27,155	26,679
Accrued liabilities	110,555	106,300
Current operating lease liabilities	11,203	10,033
Current finance lease liabilities	2,231	1,920
Total current liabilities	151,144	144,932
Non-current operating lease liabilities	197,229	198,955
Non-current finance lease liabilities	23,680	24,865
Other non-current liabilities	5,308	3,276
Total liabilities	377,361	372,028
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.001 par value per share - 5,000,000 shares authorized, none issued and outstanding at December 31, 2023 and December 31, 2022	0	0
Common stock, $0.001 par value per share - 300,000,000 shares authorized, 38,681,549 issued and outstanding at December 31, 2023; 300,000,000 shares authorized, 38,107,977 issued and outstanding at December 31, 2022	39	38
Additional paid-in capital	1,047,198	963,040
Accumulated other comprehensive loss	(3,151)	(8,124)
Retained earnings	134,858	43,904
Total stockholders’ equity	1,178,944	998,858
Total liabilities and stockholders’ equity	$ 1,556,305	$ 1,370,886

About Penumbra Inc

Penumbra, Inc., together with its subsidiairies, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, SENDit, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System, Lightning, and CAT RX brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and POD (Penumbra Occlusion Device) brand, as well as immersive 3D computer-based technology platform under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

CEO	Mr. Adam Elsesser
WEBSITE	penumbrainc.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	3900

Penumbra Inc Frequently Asked Questions

What is the ticker symbol for Penumbra Inc? What does PEN stand for in stocks?

PEN is the stock ticker symbol of Penumbra Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Penumbra Inc (PEN)?

As of Mon Apr 15 2024, market cap of Penumbra Inc is 8.14 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PEN stock?

You can check PEN's fair value in chart for subscribers.

What is the fair value of PEN stock?

You can check PEN's fair value in chart for subscribers. The fair value of Penumbra Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Penumbra Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for PEN so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Penumbra Inc a good stock to buy?

The fair value guage provides a quick view whether PEN is over valued or under valued. Whether Penumbra Inc is cheap or expensive depends on the assumptions which impact Penumbra Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PEN.

What is Penumbra Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon Apr 15 2024, PEN's PE ratio (Price to Earnings) is 89.44 and Price to Sales (PS) ratio is 7.69. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PEN PE ratio will change depending on the future growth rate expectations of investors.